Clostridium Difficile Infection Treatment Market Will Accelerate At A CAGR Of Over 5.9%
Research Viewpoint on Clostridium Difficile Infection Treatment Market Outlook: The Clostridium difficile infection treatment market is expected to grow rapidly in the next decade. Currently, the only FDA-approved treatment for CDI is vancomycin. However, this medication is only effective in about 70% of cases. There is a great need for new and improved treatments for CDI. Several companies are currently developing new treatments for CDI. One promising new treatment is fidaxomicin. Expected Growth: The global Clostridium Difficile Infection Treatment market size is projected to reach USD 1100.4 million by 2028, from USD 719.10 million in 2021, at a CAGR of 5.9% during…
- Date: November 11, 2022
- Author: Thomas Bretz
- Category: Taiwan News